Medical Devices

Themenbereich / / Medical Devices


Sortiere PresseMitteilungen nach: Titel (A\D) Datum (A\D)

Seiten sind aktuell sortiert nach: Datum (erst alte PresseMitteilungen)

Rosetta Genomics Reports Preliminary Data on Discovery of Blood-Based microRNA Signature for Identification and Stratification of Heart Failure Patients

PHILADELPHIA, PA and REHOVOT, ISRAEL -- (Marketwire) -- 07/26/11 -- (NASDAQ: ROSGD), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced preliminary data from a study it conducted in order to identify a microRNA signature in blood for congestive heart failure (HF) syndrome and to assess the feasibility to develop a minimally-invasive, microRNA-based stratification test for HF.Demographic and clinical status of HF patients in combination with indices of cardiac and renal function can identify a large proportion of high risk patients, however, risk str ...

26.07.2011

Center for Technology and Aging Awards Mobile Health Grants to CalOptima, Family Services Agency of San Francisco, Front Porch Center for Technology Innovation and Wellbeing, HealthInsight, and Sharp Healthcare Foundation

OAKLAND, CA -- (Marketwire) -- 07/27/11 -- The Center for Technology and Aging (techandaging.org), with funding from The SCAN Foundation (thescanfoundation.org), is investing a total of $477,150 in one-year grants among five organizations that will demonstrate the best ways to implement mobile health (mHealth) technologies for older adults with chronic health conditions.Using mHealth technologies for health monitoring could save from $1.96 billion to $5.83 billion in healthcare costs by the year 2014, according to Juniper Research. The five grantees are innovative public and private health an ...

27.07.2011

D. Medical To Feature Spring Product Portfolio at AADE 11 Annual Meeting & Exhibition

TIRAT CARMEL, ISRAEL -- (Marketwire) -- 07/28/11 -- D. Medical Industries Ltd. (NASDAQ: DMED)(TASE: DMED) ("D. Medical" or the "Company"), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, today announced that it is exhibiting at the American Association of Diabetes Educators 2011 Annual Meeting & Exhibition, August 3-6, 2011 in Las Vegas at Mandalay Bay Hotel and Convention Center at booth No. Booth 1910. D. Medical's exhibit will showcase ...

28.07.2011

AtCor Medical Expands Clinical Trials BP Core Lab Offering by Adding SunTech Medical's Ambulatory Blood Pressure

ITASCA, IL and MORRISVILLE, NC -- (Marketwire) -- 07/28/11 -- AtCor Medical (ASX: ACG) the developer and marketer of the SphygmoCor® system, which measures central blood pressures and arterial stiffness noninvasively, and SunTech Medical Inc., a leader in noninvasive blood pressure products and technologies, today announced that they have entered into an exclusive, multi-year worldwide clinical trials distribution and data management agreement. In addition to SphygmoCor systems, AtCor now offers trial sponsors the SunTech Oscar2™ ambulatory blood pressure monitor, the only ABPM device that h ...

28.07.2011

Brainsway Reports Final Results of PTSD Clinical Trial With Deep TMS

JERUSALEM, ISRAEL -- (Marketwire) -- 07/28/11 -- Brainsway Ltd. (TASE: BRIN) is pleased to announce that it has received the final results of a clinical trial performed at the Hadassah Medical Center to explore the efficacy of Deep TMS in the treatment of post-traumatic stress disorder (PTSD). The principal investigator of the trial was Dr. Moshe Isserles. The final results are for 26 patients (out of the 30 who enrolled in the trial), receiving at least 8 treatment sessions (the minimum amount required for treatment).Final analysis of these results has revealed that Deep TMS therapy in conj ...

28.07.2011

FDA Confirms 510K Path for Brainsway's Deep TMS Device

JERUSALEM, ISRAEL -- (Marketwire) -- 07/28/11 -- Brainsway Ltd. (TASE: BRIN) is pleased to report that the U.S. FDA has confirmed that the regulatory approval process for Brainsway's Deep TMS device for the treatment of major depression disorder (MDD) will be the Pre-Market Notification (510(k)) process. This is the simpler and faster route, which is required in a case where the device is equivalent in usability, safety and efficacy to an approved predicate device.To the best of the company's knowledge, the duration of such a route is usually between three and 12 months from the da ...

28.07.2011

CML HealthCare Inc. Announces Release Date for 2011 Second Quarter Financial Results

MISSISSAUGA, ONTARIO -- (Marketwire) -- 07/28/11 -- CML HealthCare Inc. (TSX: CLC), will release its 2011 second quarter financial results via prior to markets opening on August 11, 2011. Following the release, CML HealthCare management will host a conference call at 10:00 a.m. (ET) chaired by Patrice Merrin, Interim CEO and Chairman of the Board. Investors and analysts are invited to join the call by dialing 416-340-2216 or 866-226-1792. Please dial in 15 minutes prior to the call to secure a line. You will be put on hold until the conference call begins.A live audio webcast of the confere ...

28.07.2011

NuVasive Announces Appointment of Peter Leddy, Ph.D., to the NuVasive Board of Directors

SAN DIEGO, CA -- (Marketwire) -- 07/28/11 -- NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that Peter Leddy, Ph.D., has been named to the NuVasive Board of Directors. Leddy is Senior Vice President of Global Human Resources at Life Technologies Corp.Alex Lukianov, Chairman and Chief Executive Officer of NuVasive, said "Dr. Leddy brings a proven track record of building a culture of innovation at Life Technologies. His extensive knowledge evolving human resource practices ...

28.07.2011

New Drug Approvals in 2011 Already Match 2010 Total

SAN FRANCISCO, CA -- (Marketwire) -- 08/01/11 -- The July approval of AstraZeneca's blood-thinner Brilinta, a potential blockbuster that will compete against Plavix, marks a milestone for the U.S. Food and Drug Administration. It brings to 21 the total of new drugs approved by the agency this year, a number that equals the total of all new drug approvals in 2010, according Burrill & Company."We're on our way to breaking the anemic pace of new drug approvals of recent years, but the problems underlying the relatively low rate of approvals since 2004 still need to be address ...

01.08.2011

Beacon Endoscopic Ltd. Secures Series B Financing Through MVM Life Science Partners

NEWTON, MA -- (Marketwire) -- 08/01/11 -- Beacon Endoscopic Inc., a developer of interventional GI and bronchial endoscopy products, announced that its London-based affiliate, Beacon Endoscopic Ltd., has secured $5 million in financing from MVM Life Science Partners, a London and Boston-based growth capital provider. The company also announced that it received a new round of capital from its existing investors.In connection with the financing, Dr. Stephen Reeders, a founding partner at MVM, will join the board of Beacon Endoscopic Inc., alongside CEO Peter Rogal and co-founders Brian Tinkham ...

01.08.2011

D. Medical Inks First U.S. Distribution Deal for Spring Universal Infusion Sets

TIRAT CARMEL, ISRAEL -- (Marketwire) -- 08/02/11 -- D. Medical Industries Ltd. (NASDAQ: DMED)(TASE: DMED) ("D. Medical" or the "Company"), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, announced today that its subsidiary, Spring Health Solutions Inc. ("Spring Health"), has signed a non-exclusive distribution agreement with RGH Enterprises, Inc. ("RGH"), the parent company of Edgepark Medical Supplies and Independence Medical, ...

02.08.2011

Bio-Rad Reports Second-Quarter Revenue Growth of 11.5 Percent

HERCULES, CA -- (Marketwire) -- 08/02/11 -- Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial results today for the second quarter ended June 30, 2011.Second-quarter reported revenues were $521.7 million, up 11.5% compared to $467.7 million reported for the second quarter of 2010. On a currency-neutral basis, quarterly revenues increased 4.2% compared to the same period last year. This improvement is the result of organic growth across Bio-Rad's primary se ...

02.08.2011

D. Medical Consummates the Sale of its Holdings in its Publicly Held Subsidiary, NextGen Biomed Ltd.

TIRAT CARMEL, ISRAEL -- (Marketwire) -- 08/03/11 -- D. Medical Industries Ltd. (NASDAQ: DMED)(TASE: DMED) ("D. Medical" or the "Company"), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, announced today the closing of the sale of its holdings in its publicly held subsidiary, NextGen Biomed Ltd. for a total consideration, following closing adjustments, of NIS 5.5 Million (approximately US$1.6 Million).About D. MedicalD. Medical is a medical device c ...

03.08.2011

Sunshine Heart Appoints New US Board Member

SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN -- (Marketwire) -- 08/03/11 -- Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate heart failure, today announced the appointment of Gregory Waller as an independent non-executive director. Mr. Waller brings more than 30 years of financial management and industry experience to Sunshine Heart with an established history of serving on the boards of several successful medical device companies. He is the second US-based board member to be appointed this year following the appointment of Paul Buckm ...

03.08.2011

Syneron Stands Behind Their Commitment in Supporting the Growth and Advancements in Dermatology

YOKNEAM, ISRAEL -- (Marketwire) -- 08/03/11 -- Syneron Medical Ltd. (NASDAQ: ELOS), , the global leader in medical aesthetic devices, remains dedicated in delivering the company's commitment to science, results and trust for the Dermatology community with novel offerings supported by leading industry experts as to be displayed at the AAD's Summer Academy Meeting to be held on August 3-7, 2011 at the Hilton New York in New York, NY."Educational extensions like the Summer Academy Meeting hosted by the American Academy of Dermatology motivates us throughout the year to pioneer in ...

03.08.2011

NTEC Presents MEDVENTURES 2011 Connecting Medical Device Companies and Investors

FRISCO, TX -- (Marketwire) -- 08/03/11 -- The North Texas Enterprise Center (NTEC) for Technology, leading regional non-profit organization dedicated to assisting medical technology start-up companies, announced today that . This is one of the premier conferences in the U.S. for bringing together Medical Device Companies and Investors. Past MedVentures presenters have raised more than $30 million in investment funding after their participation in the conference.This 5th annual, early-stage investment and education conference and company showcase focuses on the medical technology sector.The p ...

03.08.2011

Given Imaging Reports Second Quarter 2011 Results

YOQNEAM, ISRAEL -- (Marketwire) -- 08/03/11 -- Given Imaging Ltd. (NASDAQ: GIVN) today announced financial results for the second quarter ended June 30, 2011.Worldwide revenues were $44.8 million in the second quarter of 2011, a 6.3 percent increase from $42.1 million in the second quarter of 2010. Gross margin on a non-GAAP basis in the second quarter of 2011 was 76.0 percent, compared to 77.3 percent in the second quarter of 2010 due to certain one-time charges. The Company anticipates that gross margin for the remainder of the year will be higher and in line with company projections.Non-GA ...

03.08.2011

Update: NTEC Presents MEDVENTURES 2011 Connecting Medical Device Companies and Investors

FRISCO, TX -- (Marketwire) -- 08/03/11 -- The North Texas Enterprise Center (NTEC) for Technology, leading regional non-profit organization dedicated to assisting medical technology start-up companies, announced today that . This is one of the premier conferences in the U.S. for bringing together Medical Device Companies and Investors. Past MedVentures presenters have raised more than $30 million in investment funding after their participation in the conference.This 5th annual, early-stage investment and education conference and company showcase focuses on the medical technology sector.The pr ...

03.08.2011

Novadaq Reports Second Quarter 2011 Financial Results

TORONTO, ONTARIO -- (Marketwire) -- 08/04/11 -- Novadaq® Technologies Inc. (TSX: NDQ), a developer of real-time medical imaging systems for use in the operating room, today announced its financial results for the second quarter ended June 30, 2011. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States (U.S.) dollars."We are seeing continued acceleration following the February 2011 commercial launch of SPY® Systems by our partners LifeCell™ and Intuitive Surgical®," said Dr. Arun Menawat, Novadaq President and CEO. "During the secon ...

04.08.2011

Atrion Reports Second Quarter Results

ALLEN, TX -- (Marketwire) -- 08/04/11 -- Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter of 2011 diluted earnings per share were up 30% and revenues were up 12% compared to the results for the second quarter of 2010.Atrion's revenues for the quarter ended June 30, 2011 totaled $31.1 million compared with $27.9 million in the same period in 2010. On a diluted per share basis, earnings for the period increased to $3.46 as compared to $2.67 in the same period of last year. Net income for the second quarter totaled $7.0 million compared to $5.4 million in last ...

04.08.2011


Page 1 from 104:  1 2  3  4  5  .. » 104





All members: 9 437
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 57


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.